| 131 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Pediatric Oncology |
2021 |
| 132 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Clinical Pathology |
2021 |
| 133 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Pediatric Oncology |
2021 |
| 134 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Pediatric Oncology |
2021 |
| 135 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Pediatric Oncology |
2021 |
| 136 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Pediatric Oncology |
2021 |
| 137 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Clinical Pathology |
2021 |
| 138 |
Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt |
Department of Pediatric Oncology |
2021 |
| 139 |
Clinical Significance of Androgen Receptor (Histo-score) in Non-metastatic, Hormonal Positive Her2-neu Negative Breast Cancer |
|
2021 |
| 140 |
Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
|
Department of Biostatistics and Cancer Epidemiology |
2021 |
